GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
1.1k
c/glp1science·posted 4 months ago by u/not_my_main_nm

[Meta] the mechanism rule is doing its job and people should stop complaining

Speculation The Quiet One ×4 Well Actually ×3

Putting this to the board: the mechanism rule is doing its job and people should stop complaining.

The half-life explanation was the thing that made weekly dosing intuitive for me rather than arbitrary.

Was completely wrong about the gastric emptying story in a thread here two years ago. Someone corrected me with a citation and I have not made that mistake since.

Spent an evening on the receptor distribution literature and the side-effect map suddenly stopped looking random.

Would rather be corrected in public than confident in private.

1,336 up / 268 down83% upvoted51 commentsid x3z8ej11 Mar 2026

51 comments

27 in this archive, depth 5

best — the order this archive was captured in

u/gustav_vermeulen131 points·4 months ago

Receptor expression in a tissue is necessary but not sufficient for an effect. You also need the agonist to reach it at relevant exposure, and that is where a lot of confident mechanism talk falls down.

replysharereportpermalink
u/noor_hovland90 points·4 months ago

Glucose-dependent insulin secretion is why hypoglycaemia risk is low as monotherapy: the effect scales with glycaemia rather than acting unconditionally.

replysharereportpermalink
u/sanne_delgado30 points·4 months ago

Agreed that receptor distribution is the key to the side-effect map. It is not a mystery, it is anatomy.

replysharereportpermalink
u/anya_salgado20 points·4 months ago

Not convinced by the linearity assumption. Dose-response in this class is not linear and the trials show it.

replysharereportpermalink
u/hassan_ostergaard0 points·4 months ago

I would not read that in vitro number across to a person. The conditions are nothing like physiological.

replysharereportpermalink
u/gastric_emptying_g1 point·4 months ago

That conflates receptor affinity with clinical potency. They are related and they are not the same thing.

replysharereportpermalink
u/signe_boateng1 point·4 months ago

Tolerance to the gastric effect develops with continued exposure while the appetite effect largely persists. That single fact explains most of the "it settles but it still works" pattern the side-effect board reports.

replysharereportpermalink
u/runa_cabrera43 points·4 months ago

Careful — you have a plausible mechanism and no evidence that it is the operative one in the case you are describing.

replysharereportpermalink
u/camila_lindqvist36 points·4 months ago·edited

Disagree. That is a preclinical finding in a rodent model and you are stating it as human pharmacology.

replysharereportpermalink
u/amara_dziedzic24 points·4 months ago

read the discussion section, that is where the honesty lives

replysharereportpermalink
u/vikram_mbeki8 points·4 months ago

Push back: a receptor being expressed in a tissue does not tell you the agonist reaches it at therapeutic exposure.

replysharereportpermalink
u/rina_bergstrom4 points·4 months ago

the peripheral and central stories are not in competition

replysharereportpermalink
[deleted]3 points·4 months ago

[deleted]

replysharereportpermalink
u/rafael_ostergaard30 points·4 months ago

gastric emptying slows, it does not stop

replysharereportpermalink
u/second_week_sceptic21 points·4 months ago

Does the effect persist with continued dosing or does tolerance develop?

replysharereportpermalink
u/karma_irrelevant18 points·4 months ago

Why mechanism talk keeps misleading people, including me.

A mechanism tells you a direction. It does not tell you a magnitude, a timescale, or whether the pathway is operative at the exposures involved. "Receptor X is expressed in tissue Y" is a fact; "therefore effect Z in a person" is a hypothesis with several missing steps.

The corrective is boring and it works: ask whether the evidence is preclinical or human, ask what exposure was used, and read the limitations section before the abstract. Most of the confidently wrong posts on this board — several of them mine — skipped all three.

replysharereportpermalink
u/not_my_main_nmOP0 points·4 months ago

Correcting my own comment: I attributed that to the GIP arm and the paper attributes it to the GLP-1 arm.

replysharereportpermalink
u/hassan_castellanos13 points·4 months ago

Right — mechanism gives you a direction. It never gives you an effect size and people use it as though it does.

replysharereportpermalink
u/flair_enthusiast13 points·4 months ago

preclinical is not clinical and rodents are not small people

replysharereportpermalink
u/emeka_chowdhury15 points·4 months ago

tolerance to the gastric effect develops, appetite effect largely persists

replysharereportpermalink
u/vomit_free_since12 points·4 months ago

Same view. Tolerance developing to the gastric effect while the appetite effect persists explains most of what the side-effect board reports.

replysharereportpermalink
u/not_my_main_nmOP-18 points·4 months ago

Same view.

Adding the caveat the paper itself makes in its limitations section, which is stronger than anything in this thread.

replysharereportpermalink
u/anders_kuusela1 point·4 months ago

receptor agonism is not the same as receptor activation in every tissue

replysharereportpermalink
u/georgi_chowdhury1 point·4 months ago

GIP receptor biology is genuinely unsettled — there is a live argument about agonism versus antagonism at the receptor — and the clinical results are robust regardless, which is an uncomfortable and interesting position.

replysharereportpermalink
u/bastian_eriksen1 point·4 months ago

the central appetite effect is doing more work than the gut effect

replysharereportpermalink
u/kavya_kravchenko9 points·4 months ago

This. Albumin binding and modification are why the half-life is what it is, and it is a design decision rather than an accident.

replysharereportpermalink
u/fatima_kowalski6 points·4 months ago·edited

The incretin effect is the observation that oral glucose provokes a larger insulin response than intravenous glucose at matched glycaemia, and the difference is mediated by gut hormones. That is the foundation the whole class sits on.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1science

The mechanism layer: incretin physiology, receptor distribution, gastric emptying, central appetite signalling, glucagon-receptor contribution, amylin co-agonism, and the pharmacokinetics that make weekly dosing possible. Papers get cited by journal and year or they get a [needs source] reply.

50kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/glp1science rules
  1. Cite the paper: journal, year, first author. Links optional, citation mandatory.
  2. Mechanistic speculation is welcome if flaired as speculation.
  3. No extrapolating rodent data to human dosing without saying that is what you are doing.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.